Product Images Dexamethasone Sodium Phosphate

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 9 images provide visual information about the product associated with Dexamethasone Sodium Phosphate NDC 51662-1370 by Hf Acquisition Co Llc, Dba Healthfirst, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

DOSAGE 1 - Dosage 1

DOSAGE 1 - Dosage 1

This is a set of recommended dosages for different authors for a medication administered intravenously. Dosages vary from a constant infusion over 24 hours after an initial injection to a single injection of 1-6 mg/kg of body weight.*

DOSAGE 2 - Dosage 2

DOSAGE 2 - Dosage 2

This appears to be a table that provides recommended dosages of Dexamethasone Phosphate (in milligrams) for different types of injection sites, including large joints (e.g., knee), small joints (e.g., Temporomandibular), bursae, tendon sheaths, soft tissue infiltration, and ganglia.*

HOW SUPLIED - How Supplied

HOW SUPLIED - How Supplied

The given text provides information about Dexamethasone Sodium Phosphate Injection, USP which is available in three different types of packagings based on the volume of fill and the dosage strength. These packages are in the form of flip-top vials and are numbered as 16501, 16505 and 16530 with NDC codes 63323-165-. The details of the volume, dosage strength, and packaging quantity of each of the three variants are provided in the text.*

LOGO - Logo

LOGO - Logo

SERIALIZED VIAL LABELING - Serialized Vial Labeling

SERIALIZED VIAL LABELING - Serialized Vial Labeling

This document contains information about a pharmaceutical product called Jexamethasone, which is meant for intravenous use. The product is supplied in a multiple dose vial, containing 5mL of solution. The vial may be used for routes of administration other than intravenous, however further instructions should be sought for such use. The document also contains a unique product number (01)00351662137017 and a manufacture date of 17th November 2011.*

STRUCTURE - Structure

STRUCTURE - Structure

The text appears to be a chemical formula description for two compounds: one is CH,0PO(ONa) and the other is C,,H,sFNa with a molecular weight of 516.41.*

VIAL 1 - Vial 1

VIAL 1 - Vial 1

VIAL 2 - Vial 2

VIAL 2 - Vial 2

This appears to be the label of a medication or medical product called "ckagĀ® B" that must be stored in a sterile environment at a controlled temperature. The recommended dosage information is not present and must be found on a separate insert. The product should be protected from heat and should not be used if a precipitate is present.*

VIAL 3 - Vial 3

VIAL 3 - Vial 3

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.